Company Filing History:
Years Active: 2014-2016
Title: The Innovations of Hans Haeberle
Introduction
Hans Haeberle is a notable inventor based in Maselheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of CCR3 inhibitors. With a total of 2 patents, his work has the potential to impact the treatment and prevention of diseases related to the CCR3 receptor.
Latest Patents
Haeberle's latest patents focus on co-crystals and salts of CCR3 inhibitors. These inventions relate to pharmaceutical compositions that contain these co-crystals and salts, as well as methods for using them as agents for the treatment and prevention of diseases associated with the CCR3 receptor. His innovative approach in this area showcases his commitment to advancing medical science.
Career Highlights
Hans Haeberle is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of Haeberle's coworkers include Markus Frank and Manuel Henry. Their collaboration fosters a dynamic environment for innovation and the advancement of pharmaceutical technologies.
Conclusion
Hans Haeberle's contributions to the field of pharmaceuticals through his patents and work at Boehringer Ingelheim International GmbH highlight his role as a key innovator. His research on CCR3 inhibitors is paving the way for new treatments that could significantly benefit patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.